News Releases

12
Sep

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in Zejula®, Currently Approved for the Treatment of Ovarian Cancer with Additional Indications Under Development

– Zejula’s multiple pipeline indications offer significant upside potential – – Transaction builds on DRI’s history of investing in innovative oncology therapies – – Long-term asset with…

4
Aug

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust will participate in the following investor conferences in August and September: Canaccord…

3
Aug

DRI Healthcare Trust Reports Second Quarter 2022 Results

– Continued strong financial results and cash generation from existing assets – – Addition of pegcetacoplan to royalty portfolio subsequent to quarter end – TORONTO, Aug. 3, 2022 /CNW/ – DRI…

21
Jul

DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 4, 2022

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its second quarter 2022 financial results on Thursday, August 4,…

21
Jul

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of pegcetacoplan Including Empaveli® /Aspaveli® for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

– Transaction builds on DRI’s history of investing in innovative therapies for the treatment of hematological conditions – – Creative deal structure provides DRI with option to increase…

11
May

DRI Healthcare Trust Announces Voting Results of AGM

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) is pleased to announce results of voting at its annual general meeting (“AGM”) of unitholders held on May 11, 2022. All of…

10
May

DRI Healthcare Trust Reports First Quarter 2022 Results

– Continued strong performance of existing assets and financial results – – Completion of Vonjo™ royalty transaction – TORONTO, May 10, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX:…

27
Apr

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust will participate in the following investor conferences in the month of May: Bloom Burton & Co….

27
Apr

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its first quarter 2022 financial results on Wednesday, May 11, 2022, at

20
Apr

DRI Healthcare Trust Announces Upsized Credit Facility

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into an amended and restated credit agreement (the “Amended…